SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-11-052675
Filing Date
2011-11-09
Accepted
2011-11-09 16:30:57
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 PDL BIOPHARMA, INC 10-Q 9-30-2011 form10q.htm 10-Q 1182885
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12925
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12938
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 9663
11 logo.jpg GRAPHIC 17249
  Complete submission text file 0001140361-11-052675.txt   7041001

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pdli-20110930.xml EX-101.INS 1225661
6 XBRL TAXONOMY EXTENSION SCHEMA pdli-20110930.xsd EX-101.SCH 44175
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdli-20110930_cal.xml EX-101.CAL 77180
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdli-20110930_def.xml EX-101.DEF 99879
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdli-20110930_lab.xml EX-101.LAB 487002
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdli-20110930_pre.xml EX-101.PRE 273093
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 111192057
SIC: 2836 Biological Products, (No Diagnostic Substances)